Tenaya Therapeutics Inc is trading 5.2% up at $0.71 today, appearing to stage a modest rebound following recent downward pressure.
- The stock's gain follows a 5.4% drop to $0.68 during the previous trading session on June 16.
- There are currently no fresh company-specific headlines, FDA updates, clinical trial readouts, or analyst rating changes to explain the move.
- The price action appears to be a technical recovery in a low-priced biotech name rather than a reaction to a specific fundamental catalyst.